Biotechnological Hub of the NIB (BTH-NIB)

The purpose of the investment project BTH-NIB is the assurance of the appropriate infrastructural conditions for the use of research and developmental opportunities in the fields of operation of the NIB.

Play Video About project      Publication

04 Nov
Dr. Bojana Žegura visited the Institute for Genetic Engineering and Biotechnology to discuss the latest results in toxicological research on nanomaterials

Submit to FacebookSubmit to Google PlusSubmit to TwitterSubmit to LinkedInPrint me

Dr. Bojana Žegura, as part of the ARIS bilateral project 3D-ToX (BI-BA/24-25-27) and the HEU project CutCancer (101079113), visited Dr. Anja Haverić and Dr. Sanin Haverić and their research team at the Institute for Genetic Engineering and Biotechnology (INGEB) in Sarajevo, Bosnia and Herzegovina.

They discussed the latest results in toxicological research on nanomaterials, specifically graphene quantum dots (GQDs) in advanced HepG2 spheroid cell models, representing a significant step forward in understanding their biological impacts and potential applications in biomedicine.

Additionally, they explored the setup of new equipment in their laboratories, specifically the latest CelVivo Clinostar bioreactor technology for cultivating 3D cell models (spheroids), which will significantly enhance the research capabilities of the group.